Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Total revenue $ 7,285 $ 5,678
Operating expenses:    
Cost of goods sold (879)  
Research and development (28,857) (35,207)
Selling, general and administrative (23,282) (19,732)
Total operating expenses (53,018) (54,939)
Loss from operations (45,733) (49,261)
Interest income 910 1,345
Interest expense (1,881)  
Other income (expense), net (305) (61)
Loss before income tax expense (47,009) (47,977)
Income tax expense (575) (526)
Net loss attributable to ordinary shareholders $ (47,584) $ (48,503)
Net loss per ordinary share    
Basic net loss per share (in dollars per share) $ (0.03) $ (0.03)
Diluted net loss per share (in dollars per share) $ (0.03) $ (0.03)
Weighted average shares outstanding:    
Weighted average shares outstanding, Basic 1,542,159,622 1,451,241,661
Weighted average shares outstanding, Diluted 1,542,159,622 1,451,241,661
Product revenue, net    
Total revenue $ 4,048  
Development revenue    
Total revenue $ 3,237 $ 5,678